- ►diabetesjournals.org J Rosenstock, JC Cappelleri, B Bolinder, RA … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Of the 60 patients who received inhaled insulin during the parent studies, 85.0%
(n = 51) chose to continue treatment, 13.3% (n = 8) switched to subcutaneous insulin, and
1.7% (n = 1) did not continue. Of the 61 patients who received subcutaneous insulin, ... Cited by 132 - Related articles - BL Direct - All 12 versions
- ►diabetesjournals.org N Freemantle, L Blonde, D Duhot, M Hompesch, R … - Diabetes Care, 2005 - Am Diabetes Assoc Inhaled insulin (INH, Exubera) is under investigation for preprandial treatment of patients with
type 1 and type 2 diabetes (1–3). This dry-powder insulin formulation is delivered by
aerosol, permitting the noninvasive administration of rapid-acting insulin (4). Preliminary ... Cited by 102 - Related articles - All 7 versions
- ►annals.org [PDF] J Rosenstock, B Zinman, LJ Murphy, SC … - Annals of internal …, 2005 - Am Coll Physicians Inhaled Insulin Improves Glycemic Control When Substituted for or ... Added to Oral Combination
Therapy in Type 2 Diabetes ... Julio Rosenstock, MD; Bernard Zinman, MD; Liam J. Murphy,
MD; Stephen C. Clement, MD; Paul Moore, MD; C. Keith Bowering, MD; Rosa Hendler, ... Cited by 163 - Related articles - BL Direct - All 8 versions
PA Hollander, L Blonde, R Rowe, AE Mehta, JL … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS— HbA 1c decreased similarly in the inhaled (−0.7%) and subcutaneous (−0.6%) insulin
groups (adjusted treatment group difference: −0.07%, 95% CI −0.32 to 0.17). HbA 1c <7.0% was
achieved in more patients receiving inhaled (46.9%) than subcutaneous (31.7%) insulin ( ... Cited by 237 - Related articles - BL Direct - All 21 versions
- ►diabetesjournals.org K Rave, S Bott, L Heinemann, S Sha, RHA Becker, … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—INH had a faster onset of action than both RHI and ILP, as indicated by shorter time
to early half-maximal effect (32 vs. 48 and 41 min, respectively; P < 0.001 for IHN vs. RHI and
P < 0.05 for IHN vs. ILP). Time to maximal effect was comparable between INH and ILP ... Cited by 112 - Related articles - All 7 versions
- ►endojournals.org SE Fineberg, T Kawabata, D Finco-Kent, C Liu, … - Journal of Clinical …, 2005 - Endocrine Soc Research Design and Methods: Insulin antibody data from initial phase II/III trials were analyzed
comparing the efficacy and safety of inhaled insulin with various agents, including sc insulin.
Additionally, data from a 24-month extension of the phase III studies were examined. Data ... Cited by 119 - Related articles - All 6 versions
JS Skyler, RS Weinstock, P Raskin, JF Yale, E … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean glycosylated hemoglobin (A1C) decreased comparably from baseline in the
inhaled and subcutaneous insulin groups (−0.3 and −0.1%, respectively; adjusted difference
−0.16% [CI −0.34 to 0.01]), with a similar percentage of subjects achieving A1C <7%. ... Cited by 104 - Related articles - BL Direct - All 10 versions
JC Cappelleri, WT Cefalu, J Rosenstock, IA Kourides, … - Clinical therapeutics, 2002 - Elsevier Methods: This was a 12-week randomized, open-label, parallel-group, controlled trial in patients
with type 2 diabetes. They were randomized to receive either a subcutaneous insulin regimen
(split/mixed insulin with 2 to 3 injections daily) or an inhaled insulin regimen (inhaled ... Cited by 78 - Related articles - All 5 versions
RA Gerber, JC Cappelleri, IA Kourides, RA Gelfand - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Subjects with type 1 diabetes participated in a 12-week
open-label trial and were randomized to either an inhaled insulin regimen or a subcutaneous
insulin regimen. Subjects (n = 69) were asked to complete a 15-item self-administered ... Cited by 101 - Related articles - BL Direct - All 8 versions
RA DeFronzo, RM Bergenstal, WT Cefalu, J Pullman, S … - Diabetes Care, 2005 - cat.inist.fr OBJECTIVE- Effective type 2 diabetes management requires prompt intervention if glycemic
control is not achieved by nonpharmacological means. This study investigates whether inhaled
insulin(INH; Exubera) can achieve target glycemic control in patients failing on diet and ... Cited by 73 - Related articles - BL Direct - All 5 versions
